Craxi, Antonio

Publishing since 1976 (Dinosaur)

Has published 194 publications in 35 years

Number of publications published per year by Craxi, Antonio. (Source : PubMed)

Distribution of publications types for Craxi, Antonio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.  Dig Liver Dis  2010;42;2  
•  Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.  Dig Liver Dis  2010  
•  Antaki N, Craxi A, Kamal S, Moucari R, Van der Merwe S, Haffar S, Gadano A, Zein N, Lai CL, Pawlotsky JM, Heathcote EJ, Dusheiko G, Marcellin P. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.  Liver Int.  2009  
•  Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.  Hepatology  2009  
•  Cabibbo G, Enea M, Attanasio M, Bruix J, Craxì A, Cammà C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.  Hepatology  2009  
•  Craxì A. PEG IFN alfa-2a vs. alfa-2b: And the winner is ...?  J. Hepatol.  2009  
•  Cammà C, Cabibbo G, Bronte F, Enea M, Licata A, Attanasio M, Andriulli A, Craxì A. Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis.  J. Hepatol.  2009;51;4  
•  Calvaruso V, Cammà C, Di Marco V, Maimone S, Bronte F, Enea M, Dardanoni V, Manousou P, Pleguezuelo M, Xirouchakis E, Attanasio M, Dusheiko G, Burroughs AK, Craxì A. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.  J. Viral Hepat.  2009  
•  Petta S, Cammà C, DI Marco V, Calvaruso V, Enea M, Bronte F, Butera G, Cabibi D, Craxì A. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.  Aliment. Pharmacol. Ther.  2009;30;6  
•  Ferraro D, Pizzillo P, Di Marco V, Vultaggio A, Iannitto E, Venezia G, Craxì A, Di Stefano R. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?  Liver Int.  2009;29;8  

[ See timeline ] [ See all publications ]